Biogen Inc
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer’s drug Leqembi. It’s the latest round of layoffs after Biogen slashed nearly 900 jobs […]
Read More
Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer’s treatment, donanemab, and expects the agency to make a decision by the end of the year. Eli Lilly is […]
Read More
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the […]
Read More
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson Chávez | The Washington Post | Getty Images Sales of the Alzheimer’s drug Leqembi may be slow initially due to logistical requirements but could pick […]
Read More
Stocks producing the largest moves midday: Rivian, Levi Strauss, Biogen, To start with Photo voltaic and additional
In this posting META DKNG FSLR BABA Observe your favored sharesGenerate Absolutely free ACCOUNT A Rivian emblem on an Amazon.com supply electric van photographed in Chicago, Illinois, on July 21, 2022. Jamie Kelter Davis | Bloomberg | Getty Photographs Test out the companies generating headlines in midday trading. Alibaba — U.S. shares of the Chinese […]
Read More
Shares creating the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
In this write-up BE BABA BIIB LEVI Adhere to your beloved sharesMake Free of charge ACCOUNT The Levi Strauss & Co. label is observed on denims in a retail store at the Woodbury Popular Premium Retailers in Central Valley, New York, U.S., February 15, 2022. Andrew Kelly | Reuters Test out the firms creating the […]
Read More
Japanese pharma Eisai slides 4% even with Fda approval for Alzheimer’s drug
Signage for Eisai Co. at the company’s headquarters in Tokyo, Japan, on Friday, Feb. 3, 2023. Bloomberg | Bloomberg | Getty Visuals Shares of Japanese pharmaceutical huge Eisai sank Friday following the company’s Alzheimer’s drug was formally accredited by U.S. regulators overnight, prompting queries about trader sentiment surrounding the shift. Tokyo-outlined shares of Eisai fell […]
Read More
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
The Food and Drug Administration on Thursday approved the Alzheimer’s treatment Leqembi, a pivotal decision that is expected to expand access to the expensive drug for older Americans. Medicare has promised to start covering Leqembi, with some conditions, on the same day the FDA approves the antibody treatment. Leqembi is made by Japanese pharmaceutical company […]
Read More
Shares generating the largest moves midday: JD.com, Biogen, Oracle and a lot more
A JD.com truck obtaining incoming items and getting ready shipments at the Northeast China-primarily based Gu’an warehouse and distribution facility in Gu’an, Сhina. XiXinXing | iStock Editorial | Getty Photos Examine out the corporations producing headlines in midday buying and selling. Biogen — Shares of the biotech inventory dipped 3% just after Biogen revamped its […]
Read More